Now showing items 1-2 of 2

    • Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil 

      Giacomazzi, Juliana; Graudenz, Márcia Silveira; Osório, Cynthia Aparecida Bueno de Toledo; Santos, Patricia Koehler dos; Palmero, Edenir Inêz; Oliveira, Marcelo Zagonel de; Michelli, Rodrigo Augusto Depieri; Scapulatempo Neto, Cristovam; Fernandes, Gabriela de Carvalho; Achatz, Maria Isabel Alves de Souza Waddington; Martel-Planche, Ghyslaine; Soares, Fernando A.; Caleffi, Maira; Goldim, José Roberto; Hainaut, Pierre; Camey, Suzi Alves; Prolla, Patrícia Ashton (2014) [Journal article]
      Germline TP53 mutations predispose individuals to multiple cancers and are associated with Li-Fraumeni/Li-Fraumeni-Like Syndromes (LFS/LFL). The founder mutation TP53 p.R337H is detected in 0.3% of the general population ...
    • Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west african populations 

      Fye, Haddy K. S; Drakesmith, Cynthia Wright; Kramer, Holger B.; Camey, Suzi Alves; Costa, Andre Nogueira da; Jeng, Adam; Bah, Alasana; Kirk, Gregory D.; Sharif, Mohamed I. F.; Ladep, Nimzing G.; Okeke, Edith; Hainaut, Pierre; Taylor-Robinson, Simon D.; Kessler, Benedikt M.; Mendy, Maimuna E. (2013) [Journal article]
      Background: Hepatocellular Carcinoma is the third most common cause of cancer related death worldwide, often diagnosed by measuring serum AFP; a poor performance stand-alone biomarker. With the aim of improving on this, ...